[How long to wait with operations for necrotizing pancreatitis?].

Rozhl Chir

IV. Chirurgická klinika LF UKo a FNsP Bratislava, Slovenská republika.

Published: August 2010

Introduction: Severe acute pancreatitis (pancreatitis with local and systemic complications) remains a therapeutical problem. Even more complicated is ESAP (Early Severe Acute Pancreatitis), which presents itself as a fulminant form (FAP--fulminant acute pancreatitis) and subfulminant form (SFAP--subfulminant acute pancreatitis). Severity of acute pancreatitis can be assessed with help of prognostic markers. Intensive conservative treatment as a part of "pancreatic unit" dominates the therapy. Couple things remain frequently discussed. First, indications for operative treatment, of which infectious complications of the necrosis and local intraabdominal complications are generally accepted. Second, optimal time of surgical intervention remains an issue discussed. Based on recommendations, patients should not be operated on in first two weeks of disease.

Aim: Aim of the authors was to evaluate their own group of patients in terms of indication and timing of the surgical intervention.

Material And Methods: Authors analyse group of patients with acute pancreatitis, hospitalised on IVth surgical clinic of Comenius University, Bratislava in years 2006-2007. There were 125 patients in this group, 47 of these were classified as SAP (severe acute pancreatitis).

Results: 13 patients were operated on, 12 for retroperitoneal abscessus, ACS (abdominal compartment syndrome) and septic state, one patient for FAP. Patients were operated on between 17th and 80th day with average 28.8 days after onset. Overall mortality was 9.6%, mortality for SAP 21.2% and 15.4% in operated patients.

Conclusion: Authors conclude, that correctly timed surgical intervention does not aggravate mortality of patients with SAP, and ambition is to shift operation to time of necrosis and infection demarcation. Early indication in setting of failure of conservative treatment of ESAP remains discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

acute pancreatitis
24
severe acute
12
patients operated
12
conservative treatment
8
surgical intervention
8
group patients
8
acute
7
pancreatitis
7
patients
7
[how long
4

Similar Publications

GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks.

Front Clin Diabetes Healthc

January 2025

School of Medicine, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

View Article and Find Full Text PDF

Background: Drug-induced acute pancreatitis is a rare condition occurs at an incidence rate of 0.1-1.4% and represents a diagnostic challenge.

View Article and Find Full Text PDF

Objective: The study aimed to investigate the rate of conversion from laparoscopic cholecystectomy (LC) to open cholecystectomy (OC) in our population and determine the potential risk factors associated with it. Understanding these factors helps surgeons predict complex cases and plan surgeries, reducing patient risks and improving outcomes.

Methodology: A cross-sectional observational study was conducted from June 1, 2022, to May 31, 2023, at Hayatabad Medical Complex, Peshawar, on 349 patients undergoing elective LC.

View Article and Find Full Text PDF

Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis.

Korean J Gastroenterol

January 2025

Section of Haematology, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.

Microangiopathic hemolytic anemia (MAHA) is a rare subtype of hemolytic anemia characterized by elevated hemolytic markers and red blood cell destruction. Though uncommon, MAHA can occur as a complication of acute pancreatitis because of the associated inflammatory response. Patients with MAHA secondary to pancreatitis show favorable outcomes when treated with plasma exchange.

View Article and Find Full Text PDF

Identification of a novel heterozygous GPD1 missense variant in a Chinese adult patient with recurrent HTG-AP consuming a high-fat diet and heavy smoking.

BMC Med Genomics

January 2025

Department of Critical Care Medicine, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu Province, China.

Background: Glycerol-3-phosphate dehydrogenase 1 (GPD1) gene defect can cause hypertriglyceridemia (HTG), which usually occurs in infants. The gene defect has rarely been reported in adult HTG patients. In the present study, we described the clinical and functional analyses of a novel GPD1 missense variant in a Chinese adult patient with recurrent hypertriglyceridemia‑related acute pancreatitis (HTG-AP), consuming a high-fat diet and smoking heavily.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!